pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4763 |
Genomic Coordinates | chr22: 46113566 - 46113657 |
Description | Homo sapiens miR-4763 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4763-5p | |||||||||||||||||||||||||||||||||
Sequence | 19| CGCCUGCCCAGCCCUCCUGCU |39 | |||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | GATAD1 | ||||||||||||||||||||
Synonyms | CMD2B, ODAG, RG083M05.2 | ||||||||||||||||||||
Description | GATA zinc finger domain containing 1 | ||||||||||||||||||||
Transcript | NM_021167 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on GATAD1 | |||||||||||||||||||||
3'UTR of GATAD1 (miRNA target sites are highlighted) |
>GATAD1|NM_021167|3'UTR 1 TTCACAAATTAAAACTGGGTTTCCAGGCCTGGTGTGGTGGCTCACGCCTGTAGCCCCAGCTATTGCACCACTGCTCTCCA 81 AGCTGGGCAATGGAGTCAGATTCTCTTTCTTAAAAAACCACAAAAAAACTGGATTTCCAGTTCTCTAATATTCTTAGTAC 161 CACAAGATATGTCATAGGTATCTTTAAATGAAATTCTTAGCTGGAAAAGTGACTAAAAAGTTTTTCTCCTGCTACCTAGT 241 AATAAACAAATCATTGTTTATTACTGGTCACTTAGAAAATTAAAAGGGATAGGGCCAGGCACAGTGGCTTATGCCTGTAA 321 TTGCAGCACTTTTAGAGGCCGAGGCAGGCGGATCACCTGAGGTCGGGAAGTGGATCGCCTGAGGTCAGGAGTTCGAGACC 401 AGCCTGGCCAACATGGCGAAACCCCGTCGCTACTAAAAATACAAAAATTAGCCAGGTGTGGTGGCATGTGCCTGTAATCC 481 CAGCTATTTGGGAGGCTGAGGCAGGAGAATCGCCTAAACCCAGGAGGTGGAGGTTGTAGTGAGCCAAGATTGCACCGCTG 561 TGCTCCAGCCTGGGCAACAGAGTGAGACTCTTGTCTCGGAAAAAAAAAAAAAAAAAAAAGGCTGGGCACAGTGGCTCACG 641 CCTTTAATCCCAGCACTTTGGGAGGCTGAGGCAGATGGATCGCCTGAGGTTGGGAGTTCGAGACCAGCCTGGCCAGCATG 721 GTGAAACCCTGTCTCTACTAAAAATACAAAAATTAGCCAGGTGTGGTGGCGCACACCTGTAGTCCCAGCTACTCGGGAGG 801 CTGAGGCAGGAGAATTGGTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCAGAGATCGTGCCACTGCACTCCAGCCTGGGT 881 GGACAGAGCAAGACTCCGTCTCAAAGAAACAAACAAAAAATTAAAAGGGATAGAATATAATGAAATATATTTTGAACTTA 961 AATTATATTCTATATGTGTATCTTCCTAGGCAAAAGCTGTAATTTCCAGAGAGACCATTAGGAACAGGTAGTATCTATTT 1041 TTCTCCATTATTTATTTCTAGAAACTCATAAAATGGATTGTATTTTTCTATAAGAACAAAATATTAATTAAGGTATAGAT 1121 GACTGACCAAGGGCTTAATCAAATAAAATGACTAACAGCATCTATCATAAAGCCACACAAGCCTTATGTTCTCATCTCAA 1201 AAATGCTGTGACAGCTTTTTGGCTGCTTTAACCATAAGAAAAATGATTGGTGGATGATTTTATTAGCCCAGGCTTTTAAA 1281 AACTTTCATCTAGGCCACGTGCGGTGGCTCATGCCTGTAATCCCGGCACTTTGGGAGGCCTGAGTGGATGGATCACTTGA 1361 GGTCAGGAGTTCAGGACCAGCCTGGCCAACATGATGAAACCCTGTCTCTACTAAATATACAAAAATTAGTTGGGTGTTAT 1441 GGTGCATGCCTGTAATCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATTGCTTGAACTCGGGAGGTGGAGATTGCAGTAA 1521 GCCGAGATCGTGCCACTGCACTCCAGCCTGGGTGATAGAGCAAGACTGTCTCAAAAAAGAAAAAAAAGAAAAAATTTTAA 1601 TTTAATCCTTCTGTAGAAACAGGCATTCAGAACCATTCCATTGATCTTAATAAAGCTGCTCTTTACTGTTTCTAGTCAAA 1681 AATGAGACTTCGATCAAACCATAAGATTTTATACTGCAGATAGTCAGCTTCACCAAAGCCGCAGAGGAAACATGTCGAGA 1761 TCAGGCTTCCTGCTTGATAGTCTCTTGACTACCATTAAAACGAATATTGGGAGGTCATGAAAGTCATTGGTAGGCCATTA 1841 GCATTGATATCTTTAAAACATCTACCCTAAACCATCTGCTATGGACCCATAATAAGAGGCCTGTTGTATATGAAATTGTC 1921 TAGAATTCAGGTGCAGGTCTTTGCCGGTTAAGTAAGGGAGCAACACGTAAAATGGGAGAGGAGTGGGGTGTACTCACTTG 2001 CCTCCTCTTTTGTCCTGATTTAACCAGCATTTTTCAACCCTGGGAAAATTTGCAGAATCTAAGTTGATTGTAATGATTTT 2081 GAGCTGCAGCAGCTTTAACTCTTACCCTTTTTCCACATAGTTATGGTGTTTGAGTTGGAAAGAAACAACTATAGGTAGCT 2161 ACACGTACATAATTATCTCTTTATTCACAAAGGGTATAGTAAAATTGATTGTAAATAACTTTCTAAGTGCCAATATTCAA 2241 AACTTTTGGATTAAAATGTATTTTTCACCGTGCATTTACTTTGGATGTATTTATTTCATTTAAACAATTTAAATGGGGCT 2321 CTTTAACCAAAAATGGTATTTAAAACCAAAACAGTATCGTACTTAGAATTTGGAGTAGAGGCCGGGCACAGTGGCTCACG 2401 CCTGTAATCCCAGCACTTTGGAAGGCTGAGGCAGGCGGATCACCTGAGGTCAGGAGTTCGAGACCAGCCTGGTCAACATG 2481 AAACCCCGTCTCTACTAAAAATACAAAAATTAGCTGGGCGTGGTGGCGTGCGCCTATAATCCCAGCTAGTCTACTCGGGA 2561 GGCTGAGGCAGGAGAATCGCTGGAACTCAGGAGGCAGAGACTGCAGTGAGCCGAGATCGCGCCACTGCACTCCAGTCTGG 2641 GTGACGGCATGACTCCATCTCCAAAAAAAAAAAAAAAAGATTTTGGAGTAGATTCATCATTAATAAGTAACAGATTTTAG 2721 GAAAATCAAAAAATGGCTAATAAAATGAACACAATGTAAAACATTTATTAAAATGTAGACTTTTAAAAATCTATAAATTG 2801 ATCATCTGTTTATAAATTGGCAGATGGTTGTGTACCATCTTTTAAAATAAAGATTGAATTTCACCCAGTGTGATGGTTCC 2881 CATTGCTTATATTTCTCCTGCTGAGGCCGGACCTGATATGGCCCTGGTCTGTGTTCCCAGCCTTGTTTCCTCATTACCAC 2961 TAAAATCTTTCCCCTGTATGCCCGCCCAATTTTTCTGGCTCTGAGTCCTTGTTCATACTGTTCTCTCCAATTCTACCTTC 3041 CAAAGGCCTTTCTTAACACCTTCGGATTCTTTCTTTGAGAACTTTCCAGATTCCCATGCCTTTTTGGAATCAATCTCTAT 3121 CCTATTGTCATCACATTTAAGTTTCTACTTCCATCATCCTCACTCCTATCCCTTTGGTCCTGGGATGACAGGGATGCTGT 3201 GTTTTATTTACTCATCTTTGTAACTTCCACATAACCTAACCCCGGTTCTTGCTTATGGGAGATGCTGATTGTAGGGTCTG 3281 AGTTAGATACTGTTAACTAAAATGCTTGTTGATATTTTAGTTATTAATTCATATTAACTTTGGCTGAAACTTTTAAATTC 3361 TATTGTGAATAGTCAAGTAAAATTTAGATTGTTACATTCTGGGTTAGTATTAGATTGTTTTTAAGATTGTTTTAAACAAG 3441 ATGTTTTTAAGATGAGTTTTAAATAGTTCTCTTAACACAAATAAAGCTTAATATGAGTATTTGAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293S | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084040. RNA binding protein: AGO2. Condition:CLIP_noarsenite_rep1
HITS-CLIP data was present in GSM1084068. RNA binding protein: AGO2. Condition:CLIP_noemetine_SigmaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760630. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_A
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM4903825 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_NS |
Location of target site | NM_021167 | 3UTR | AGAGGCCGAGGCAGGCGGAUCACCUGAGGUCGGGAAGUGGAUCGCCUGAGGUCAGGAGUUCGAGACCAGCCUGGCCAACAUGGCGAAACCCCGUCGCUACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_021167 | 3UTR | AGGCUGAGGCAGGCGGAUCACCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1084040 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noarsenite_rep1 |
Location of target site | ENST00000287957.3 | 3UTR | UGUAAUCCCAGCACUUUGGAAGGCUGAGGCAGGCGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1084068 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noemetine_SigmaAb |
Location of target site | ENST00000287957.3 | 3UTR | AAGGCUGAGGCAGGCGGAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
69 hsa-miR-4763-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT116035 | DEPDC1 | DEP domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT347197 | SIN3B | SIN3 transcription regulator family member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT443248 | C9orf170 | chromosome 9 open reading frame 170 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475164 | IP6K1 | inositol hexakisphosphate kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT495486 | VTI1B | vesicle transport through interaction with t-SNAREs 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT496755 | TGIF2 | TGFB induced factor homeobox 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496863 | C21orf2 | chromosome 21 open reading frame 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499264 | NBPF11 | NBPF member 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499517 | MAFK | MAF bZIP transcription factor K | ![]() |
![]() |
2 | 2 | ||||||
MIRT512952 | MKI67 | marker of proliferation Ki-67 | ![]() |
![]() |
2 | 2 | ||||||
MIRT514656 | NUP93 | nucleoporin 93 | ![]() |
![]() |
2 | 2 | ||||||
MIRT517986 | SLC16A13 | solute carrier family 16 member 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT522816 | KLHL9 | kelch like family member 9 | ![]() |
![]() |
2 | 4 | ||||||
MIRT525495 | CD63 | CD63 molecule | ![]() |
![]() |
2 | 2 | ||||||
MIRT528111 | FOXH1 | forkhead box H1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT531683 | MYO3A | myosin IIIA | ![]() |
![]() |
2 | 2 | ||||||
MIRT534806 | RAB37 | RAB37, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT573041 | SHMT1 | serine hydroxymethyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT576720 | Wars | tryptophanyl-tRNA synthetase | ![]() |
![]() |
2 | 2 | ||||||
MIRT609727 | MLXIPL | MLX interacting protein like | ![]() |
![]() |
2 | 2 | ||||||
MIRT610843 | FAM180B | family with sequence similarity 180 member B | ![]() |
![]() |
2 | 4 | ||||||
MIRT614735 | STAT5A | signal transducer and activator of transcription 5A | ![]() |
![]() |
2 | 2 | ||||||
MIRT616981 | EPOR | erythropoietin receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT617265 | MMAB | methylmalonic aciduria (cobalamin deficiency) cblB type | ![]() |
![]() |
2 | 2 | ||||||
MIRT619405 | INTS7 | integrator complex subunit 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT621832 | TIMM8A | translocase of inner mitochondrial membrane 8A | ![]() |
![]() |
2 | 2 | ||||||
MIRT621893 | TAF13 | TATA-box binding protein associated factor 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT630263 | SMIM14 | small integral membrane protein 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT634879 | SENP8 | SUMO/sentrin peptidase family member, NEDD8 specific | ![]() |
![]() |
2 | 2 | ||||||
MIRT636863 | ARSE | arylsulfatase E (chondrodysplasia punctata 1) | ![]() |
![]() |
2 | 2 | ||||||
MIRT637653 | ADAT1 | adenosine deaminase, tRNA specific 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637699 | ZNF439 | zinc finger protein 439 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637759 | GATAD1 | GATA zinc finger domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT638193 | TAOK1 | TAO kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT638996 | ADO | 2-aminoethanethiol dioxygenase | ![]() |
![]() |
2 | 2 | ||||||
MIRT642221 | RABAC1 | Rab acceptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT643327 | ATCAY | ATCAY, caytaxin | ![]() |
![]() |
2 | 4 | ||||||
MIRT643419 | ERVMER34-1 | endogenous retrovirus group MER34 member 1, envelope | ![]() |
![]() |
2 | 2 | ||||||
MIRT644499 | RNF14 | ring finger protein 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT644603 | NT5DC3 | 5'-nucleotidase domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT644795 | C21orf59 | chromosome 21 open reading frame 59 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648732 | HIST1H2BD | histone cluster 1 H2B family member d | ![]() |
![]() |
2 | 2 | ||||||
MIRT653856 | SHE | Src homology 2 domain containing E | ![]() |
![]() |
2 | 2 | ||||||
MIRT654129 | RPL14 | ribosomal protein L14 | ![]() |
![]() |
2 | 4 | ||||||
MIRT658876 | DSN1 | DSN1 homolog, MIS12 kinetochore complex component | ![]() |
![]() |
2 | 2 | ||||||
MIRT671624 | C20orf144 | chromosome 20 open reading frame 144 | ![]() |
![]() |
2 | 4 | ||||||
MIRT677367 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT677579 | TRIM65 | tripartite motif containing 65 | ![]() |
![]() |
2 | 2 | ||||||
MIRT678220 | MACC1 | MACC1, MET transcriptional regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT679613 | RRP36 | ribosomal RNA processing 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT686081 | PNPLA3 | patatin like phospholipase domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT691817 | ICA1L | islet cell autoantigen 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT693869 | COX19 | COX19, cytochrome c oxidase assembly factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT694544 | BPNT1 | 3'(2'), 5'-bisphosphate nucleotidase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT694926 | ANKS4B | ankyrin repeat and sterile alpha motif domain containing 4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT697758 | USP37 | ubiquitin specific peptidase 37 | ![]() |
![]() |
2 | 2 | ||||||
MIRT697891 | UBE2B | ubiquitin conjugating enzyme E2 B | ![]() |
![]() |
2 | 2 | ||||||
MIRT701569 | MYPN | myopalladin | ![]() |
![]() |
2 | 2 | ||||||
MIRT703081 | GPRIN3 | GPRIN family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708104 | IGF2BP1 | insulin like growth factor 2 mRNA binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708320 | NT5C | 5', 3'-nucleotidase, cytosolic | ![]() |
![]() |
2 | 2 | ||||||
MIRT709878 | TRAF1 | TNF receptor associated factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713545 | GJB1 | gap junction protein beta 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT716275 | NUP85 | nucleoporin 85 | ![]() |
![]() |
2 | 2 | ||||||
MIRT716621 | CRCP | CGRP receptor component | ![]() |
![]() |
2 | 2 | ||||||
MIRT717987 | C9orf171 | cilia and flagella associated protein 77 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718438 | RAB11B | RAB11B, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT722544 | AGPAT4 | 1-acylglycerol-3-phosphate O-acyltransferase 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT724013 | F2RL1 | F2R like trypsin receptor 1 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|